Home・Aktien・Merit Medical Systems Inc

Merit Medical Systems Inc

Geschlossen

BrancheGesundheitswesen

85.82 0.36

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

84.78

Max

87.71

Schlüsselkennzahlen
By Trading Economics
Einkommen	3M 41M
Verkäufe	-12M 382M
KGV Branchendurchschnitt	32.11 64.641
EPS	0.94
Gewinnspanne	10.721
Angestellte	7,500
EBITDA	1.7M 93M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+17.12% upside

Dividenden
By Acuity
Nächstes Ergebnis	29. Okt. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	518M 4.5B
Vorheriger Eröffnungskurs	85.46
Vorheriger Schlusskurs	85.82

Nachrichtenstimmung

By Acuity

50%

151 / 340 Ranking in Healthcare

Merit Medical Systems Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Merit Medical Systems Inc Prognose

Kursziel

By TipRanks

17.12% Vorteil

12-Monats-Prognose

Durchschnitt 99.56 USD 17.12%

Hoch 114 USD

Tief 83 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Merit Medical Systems Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

Buy

Halten

Sell

Basierend auf 10 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Merit Medical Systems Inc – Dist abgegeben haben.

Stimmung

By Acuity

151 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.